For Lambert Eaton Myasthenic Syndrome (LEMS). This high cost drug is likely to require a full HTA due to significant budget impact.
Rapid Review
| Commenced | Completed | Outcome |
| 07/11/2011 | 09/12/2011 | Full Pharmacoeconomic Evaluation Recommended. |
| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Amifampridine |
| Brand | Firdapse® |
| Indication | For the treatment of Lambert Eaton Myasthenic Syndrome (LEMS) |
| Assessment Process | |
| Rapid review commissioned | 07/11/2011 |
| Rapid review completed | 09/12/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |